SPRAVATO®, the only FDA-approved nasal spray for adult patients with two forms of challenging-to-treat major depressive disorder (MDD):

• Adults with MDD who’ve had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD)
• Depressive symptoms in adults with MDD with suicidal thoughts or actions (MDSI)

See Limitations of Use below